Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 160

1.

Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insight.

Freudenreich O, Cather C, Evins AE, Henderson DC, Goff DC.

J Clin Psychiatry. 2004 Oct;65(10):1372-6.

PMID:
15491241
[PubMed - indexed for MEDLINE]
2.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
[PubMed - indexed for MEDLINE]
3.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
[PubMed - indexed for MEDLINE]
4.

First-episode schizophrenia: the importance of early intervention and subjective tolerability.

Kasper S.

J Clin Psychiatry. 1999;60 Suppl 23:5-9. Review.

PMID:
10625193
[PubMed - indexed for MEDLINE]
5.

Assessing the effects of atypical antipsychotics on negative symptoms. Collaborative Working Group on Clinical Trial Evaluations.

[No authors listed]

J Clin Psychiatry. 1998;59 Suppl 12:28-34. Review.

PMID:
9766617
[PubMed - indexed for MEDLINE]
6.

Practical issues with amisulpride in the management of patients with schizophrenia.

Pani L, Villagrán JM, Kontaxakis VP, Alptekin K.

Clin Drug Investig. 2008;28(8):465-77. Review.

PMID:
18598092
[PubMed - indexed for MEDLINE]
7.

Physical health monitoring of patients with schizophrenia.

Marder SR, Essock SM, Miller AL, Buchanan RW, Casey DE, Davis JM, Kane JM, Lieberman JA, Schooler NR, Covell N, Stroup S, Weissman EM, Wirshing DA, Hall CS, Pogach L, Pi-Sunyer X, Bigger JT Jr, Friedman A, Kleinberg D, Yevich SJ, Davis B, Shon S.

Am J Psychiatry. 2004 Aug;161(8):1334-49. Review.

PMID:
15285957
[PubMed - indexed for MEDLINE]
8.

Clozapine: efficacy and safety.

Buchanan RW.

Schizophr Bull. 1995;21(4):579-91. Review.

PMID:
8749886
[PubMed - indexed for MEDLINE]
Free Article
9.

How much do novel antipsychotics benefit the patients?

Kasper S.

Int Clin Psychopharmacol. 1998 Mar;13 Suppl 3:S71-7. Review.

PMID:
9690974
[PubMed - indexed for MEDLINE]
10.

World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia.

Tandon R, Belmaker RH, Gattaz WF, Lopez-Ibor JJ Jr, Okasha A, Singh B, Stein DJ, Olie JP, Fleischhacker WW, Moeller HJ; Section of Pharmacopsychiatry, World Psychiatric Association.

Schizophr Res. 2008 Mar;100(1-3):20-38. doi: 10.1016/j.schres.2007.11.033. Epub 2008 Feb 19. Review.

PMID:
18243663
[PubMed - indexed for MEDLINE]
11.

Effect of second-generation antipsychotics on employment and productivity in individuals with schizophrenia: an economic perspective.

Percudani M, Barbui C, Tansella M.

Pharmacoeconomics. 2004;22(11):701-18. Review.

PMID:
15250749
[PubMed - indexed for MEDLINE]
12.

Is antipsychotic medication stigmatizing for people with mental illness?

Sajatovic M, Jenkins JH.

Int Rev Psychiatry. 2007 Apr;19(2):107-12. Review.

PMID:
17464788
[PubMed - indexed for MEDLINE]
13.

Are second generation antipsychotics a distinct class?

Bonham C, Abbott C.

J Psychiatr Pract. 2008 Jul;14(4):225-31. doi: 10.1097/01.pra.0000327312.04153.da. Review.

PMID:
18664891
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Partial response to antipsychotic treatment: the patient with enduring symptoms.

Emsley RA.

J Clin Psychiatry. 1999;60 Suppl 23:10-3. Review.

PMID:
10625194
[PubMed - indexed for MEDLINE]
15.

[Leponex, 10 years after -- a clinical review].

Llorca PM, Pere JJ.

Encephale. 2004 Sep-Oct;30(5):474-91. Review. French.

PMID:
15627052
[PubMed - indexed for MEDLINE]
16.

The SOHO (Schizophrenia Outpatient Health Outcome) study: implications for the treatment of schizophrenia.

Haro JM, Salvador-Carulla L.

CNS Drugs. 2006;20(4):293-301. Review.

PMID:
16599647
[PubMed - indexed for MEDLINE]
17.

Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature.

Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV.

J Clin Psychiatry. 2002 Oct;63(10):892-909. Review.

PMID:
12416599
[PubMed - indexed for MEDLINE]
18.

The effects of clozapine on negative symptoms in patients with schizophrenia with minimal positive symptoms.

Brar JS, Chengappa KN, Parepally H, Sandman AR, Kreinbrook SB, Sheth SA, Ganguli R.

Ann Clin Psychiatry. 1997 Dec;9(4):227-34. Review.

PMID:
9511946
[PubMed - indexed for MEDLINE]
19.

Predictors of noncompliance in patients with schizophrenia.

Perkins DO.

J Clin Psychiatry. 2002 Dec;63(12):1121-8. Review.

PMID:
12523871
[PubMed - indexed for MEDLINE]
20.

Iatrogenic disorders associated with conventional vs. atypical antipsychotics.

Nasrallah HA, Mulvihill T.

Ann Clin Psychiatry. 2001 Dec;13(4):215-27. Review.

PMID:
11958363
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk